insights_auto
Why is EMCURE down 2.54%?
Dive Deeperchevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹1,869.20
arrow_downward
-2.54%(-48.80) 1D
Oct 8, 10:56:32 AM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹1,905.10
High
₹1,919.50
Low
₹1,865.90
Mkt. cap
358.63B
Avg. vol.
180.50K
Volume
20.15K
Dividend
0.19%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
35.04
52-wk high
₹2,100.70
52-wk low
₹1,306.50
EPS
₹53.35
No. of employees
7K
Open
₹1,905.10
High
₹1,919.50
Low
₹1,865.90
Mkt. cap
358.63B
Avg. vol.
180.50K
Volume
20.15K
Dividend
0.19%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
35.04
52-wk high
₹2,100.70
52-wk low
₹1,306.50
EPS
₹53.35
No. of employees
7K
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
·
16 minutes ago
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City
The Globe and Mail
·
50 minutes ago
U.S. Analyst Updates: October 7th, 2026
Simply Wall Street
·
24 minutes ago
Core Scientific (CORZ) Draws Bullish Valuation Calls, Is The Stock Still A Bargain?
Investor's Business Daily
·
2 hours ago
Futures: Memory Giant's Earnings Surge, But Miss Views
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorPharmaceutical industry
Websiteemcure.com